GREMLIN and MANGO - Clinical trial • Breast Cancer Foundation NZ


Updated: April 29, 2022

New Zealand Clinical Research is calling for male volunteers in Auckland and Christchurch to participate in two large trials looking at potential new treatments for breast cancer.

One trial is investigating a potential biosimilar, or copy, of medication Trastuzumab (commonly known as Herceptin), and the other is looking at new ways of administering current medications Herceptin and Pertuzumab.

Gremlin key inclusion requirements:

    • Healthy males
    • Aged 18 – 65 years, inclusive
    • BMI 18 – 30 kg/m2, inclusive
    • Weight 50 – 100kg
    • Smoke <5 cigarettes per week
    • No medications

    Currently recruiting

    Mango key inclusion requirements:

      • Healthy males
      • Aged 18 – 45 years
      • BMI 18.0 – 32.0 kg/m2
      • Not taking any medications

      Not currently recruiting

      New Zealand



      New Zealand Clinical Research

      If you think you might be a candidate for this trial, use the contact details supplied, or talk to your doctor.

      Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at

      Similar clinical trials

      For Screening, prevention, familial and other

      Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to

      Find clinical trials

      Interested in a clinical trial?

      Subscribe for updates & stay in the loop with new studies.